This paper is in the following e-collection/theme issue:

JMH Theme Issue: COVID-19 and Mental Health: Impact and Interventions (386) Psychotic Disorders (162) Mobile Health (mhealth) (2982) mHealth for Treatment Adherence (404) Web-based and Mobile Health Interventions (3357) Digital Mental Health Interventions, e-Mental Health and Cyberpsychology (1565)

Published on in Vol 10 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/50806, first published .
Efficacy of a Smartphone App in Enhancing Medication Adherence and Accuracy in Individuals With Schizophrenia During the COVID-19 Pandemic: Randomized Controlled Trial

Efficacy of a Smartphone App in Enhancing Medication Adherence and Accuracy in Individuals With Schizophrenia During the COVID-19 Pandemic: Randomized Controlled Trial

Efficacy of a Smartphone App in Enhancing Medication Adherence and Accuracy in Individuals With Schizophrenia During the COVID-19 Pandemic: Randomized Controlled Trial

Authors of this article:

Huan Hwa Chen1 Author Orcid Image ;   Hsin Tien Hsu2, 3 Author Orcid Image ;   Pei Chao Lin2, 3, 4, 5 Author Orcid Image ;   Chin-Yin Chen6 Author Orcid Image ;   Hsiu Fen Hsieh2, 3 Author Orcid Image ;   Chih Hung Ko2 Author Orcid Image
Article Authors Cited by (3) Tweetations (14) Metrics

Journals

  1. Wang T, Huang Y, Chan H. Exploration of Features of Mobile Applications for Medication Adherence in Asia: Narrative Review. Journal of Medical Internet Research 2024;26:e60787 View
  2. Bokhari S, Karaman M, Thalitaya M. Transient Psychotic Relapse Following COVID-19 in a Stable Schizophrenia Patient on Paliperidone Palmitate: A Case Report. Cureus 2024 View
  3. Linardon J, Fuller-Tyszkiewicz M, Firth J, Goldberg S, Anderson C, McClure Z, Torous J. Systematic review and meta-analysis of adverse events in clinical trials of mental health apps. npj Digital Medicine 2024;7(1) View